Teoxane and Revance target undereye hollows after FDA approves RHA Redensity Eye for adults 22 and older
FDA’s PMA supplement expands RHA Redensity Eye into infraorbital volume correction, backed by a 233-patient safety population and mandatory device-specific injector training.